Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Sopo Group is a major Chinese state-owned chemical enterprise and a global leader in the production of acetic acid and its derivatives. Headquartered in Zhenjiang, the company operates one of the world's largest methanol carbonylation plants for acetic acid production, supplying essential raw materials for the pharmaceutical, textile, and packaging sectors. Its product portfolio includes ethyl acetate, acetic anhydride, and azodicarbonamide (ADC) foaming agents, as well as calcium hypochlorite used for industrial disinfection. While the company does not engage in direct drug development, it is a critical upstream supplier of chemical intermediates used in the synthesis of various active pharmaceutical ingredients (APIs). The group's primary operational entity, Jiangsu Sopo Chemical Co., Ltd., is publicly traded on the Shanghai Stock Exchange.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Sopo Group.